Our funding over the years has been both public and private, some of the projects in recent years are:

PUBLIC PROJECTS

Role of VIP in the preservation of the joint integrity and funcionality 

Grants for the financing of UCM research projects 2023 (PR12/24-31568).

PI: Yasmina Juarranz Moratilla.

15-11-2024 al 14-11-2025. 

Study and validation of immunomodulatory biomarkers for the diagnosis and prognosis of patients with multiple sclerosis and spondyloarthritis

Grants for the financing of UCM research projects 2023 (PR12/24-31572).

PI: Carmen Martínez Mora.

15-11-2024 al 14-11-2025. 

Inflammation and Immunopathology of organs and systems. Red de Enfermedades Inflamatorias (REI) 

Redes de Investigación Cooperativas Orientadas a Resultados en Salud (RICORS). Carlos III Health Institute (ISCIII) (RD24/0007/0014).

PI: Carmen Martínez Mora.

01-01-2025 al 31-12-2027. 

Inflammation and Immunopathology of organs and systems. Inflammation. Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS)

Carlos III Health Institute. Ministry of Economy and Competitiveness (RD21/0002/0004).

PI: Carmen Martínez Mora.

01-01-2021 al 31-12-2025.

Regulatory mechanisms of VPAC receptor expression, signalling and function to validate their clinical application in inflammatory/autoimmune diseases

Ministry of Science, Innovation and Universities. (PI20-00078).

PI: Yasmina Juarranz Moratilla

31-12-2020 al 31-12-2023.

PREDINMUN‐COVID. Dynamics of the immune response as a predictor of the evolutionary course of COVID-19 disease. Implications for therapeutic decision-making

Proyect Fondos supera CRUE-Santander.

PI: Francisco Sánchez Madrid. PI-UCM: Rosa Pérez Gomariz. 

1-7-2020 al 31-6-2021.

VIP/receptor axis as a biomarker in rheumatic diseases and its implication in cartilage and bone destruction

Ministry of Economy and Competitiveness. (PI17/00027).

PI: Rosa Pérez Gomariz

01/01/2018 al 31/12/2020.

Red de Investigación en Inflamación y Enfermedades Reumáticas (RIER)

Carlos III Health Institute. (RD16/0012/0008).

IP: Rosa Pérez Gomariz

01/01/2017 al 31/12/2021

Development and validation of a system for the analysis of genetic and/or epigenetic biomarkers to personalise the treatment of inflammatory and autoimmune diseases

Project challenges of collaboration with companies. (RTC-2015-3562-1).

01/03/2015 al 30/04/2019.

Study of gene expression and regulation mechanisms of VIP and its receptors in Recent Onset Arthritis. Validation as a prognostic marker

Ministry of Science and Innovation. (PI14/00747).

PI: Carmen Martínez Mora

01/01/2015 al 30/06/2019.

Study of the contribution of VIP to the pathophysiology of Th17 cells and their use in the prognosis and diagnosis of rheumatic diseases

Strategic Action in Health: Sub-programme for Investigation Projects (IP) in Health. (PI12/00758).

PI: Rosa Pérez Gomariz

31/12/2012 al 31/12/2016.

Inflammation and Rheumatic Diseases Network

Strategic Action in Health: Subprograma de Redes Temáticas de Investigación Cooperativa en Salud (RETICS). (RD12/0009/0002). 

IP: Rosa Pérez Gomariz

01/01/2013 al 01/11/2017.

Rheumatoid Arthritis: Physiopathology mechanisms and identifiaction of potential therapeutic targets

Community of Madrid. (S2011/BMD-2350).

PI: Rosa Pérez Gomariz

01/01/2012 al 31/12/2015.

Study of the expression levels of VIP and its receptors in patients with recent-onset arthritis. Determination of its potential as a therapeutic biomarker

Ministry of Science and Innovation. PI11/00195.

PI: Carmen Martínez Mora

01/01/2012 al 31/12/2014.

Validation of the therapeutic effect of VIP/PACAP in rheumatic diseases

Strategic Action in Health: Sub-programme for Investigation Projects (IP) in Health. . (PI080025).

PI: Rosa Pérez Gomariz

1/01/2009 al 31/12/2012.

VIP, PACAP and Immune System

UCM Groups. GR35/10-A.

IP: Rosa Pérez Gomariz

01/01/2011 al 31/12/2011.

VIP, PACAP and Immune System

UCM Groups. GR35/10-A.

IP: Rosa Pérez Gomariz

01/01/2009 al 31/12/2010.

Red de Investigación en inflamación y enfermedades reumáticas (RIER).

Strategic Action in Health: Subprograma de Redes Temáticas de Investigación Cooperativa en Salud (RETICS). (RD08/0075/0005).

IP: Rosa Pérez Gomariz

1/01/2009 al 31/12/2010.

Study of new therapeutic targets used by the VIP/PACAP system for the treatment of inflammation induced by infection in sepsis or autoimmunity in Crohn's disease and rheumatoid arthritis

Ministry of Education and Science. (SAF2005-01438).

PI: Rosa Pérez Gomariz

2006-2008

PROJECTS ARTICLE 83

Projects. Sylentis S.A.-University Complutense of Madrid

19/07/2007 al  29/2/2008